The John A. Hartford Foundation has awarded a $750,000 renewal grant to the Center of Excellence in Geriatric Psychiatry at the University of California, San Diego (UCSD) School of Medicine.
A large, randomized drug trial has shown for the first time that statin drugs result in a modest, but significant, reduction in blood pressure, according to lead investigator Beatrice Golomb, M.D., Ph.D., associate professor of medicine at the University of California, San Diego School of Medicine and director of UC San Diego's Statin Study.
A unique partnership between industry and academia has led to human clinical trials of a new drug for a rare class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leukemia.
UC San Diego Medical Center-Hillcrest celebrates the opening of an expanded Neonatal Intensive Care Unit (NICU) designed for the 24-hour specialized care of premature infants and newborns with complications.
While investigating the tropical disease leptospirosis in the Peruvian Amazon, an infectious disease specialist from the University of California, San Diego School of Medicine has uncovered new, emerging bacteria that may be responsible for up to 40 percent of cases of the disease.
Experts no longer consider the family to be the cause of a young person's onset of anorexia; instead, the family is being looked to as a solution for this serious and potentially lethal disease.
On Wednesday, March 12, 2008, surgeons at UC San Diego Medical Center performed what is believed to be the country's first removal of a diseased appendix through the mouth. This clinical trial procedure received approval for a limited number of patients by UC San Diego's Institutional Review Board (IRB) which oversees clinical research.
In findings with the potential to provide a therapy for Alzheimer's disease patients where none now exist, a researcher at the University of California, San Diego and colleagues have demonstrated in mice a way to reduce the overproduction of a peptide associated with the disease.
When Joan Graves was a nurse at UCSD Medical Center more than fifteen years ago, a coworker promised to teach her how to crochet if she made 1,000 blankets for the babies in UCSD's Neonatal Intensive Care Unit (NICU.) Graves agreed and has crocheted hundreds of comforting bright-colored blankets for tiny "preemies" who eventually graduate from UCSD's NICU to their homes across San Diego.
A study by researchers at the University of California, San Diego School of Medicine shows there is increasing evidence that high rates of illness in Persian Gulf War Veterans can be explained, in part, by exposure to certain chemicals, including pesticides and nerve agents.
A drug to treat a rare, inherited disease that causes rash, fever, chills and joint pain in patients when they are exposed to cold temperatures has been approved by the U.S. Food and Drug Administration (FDA). The therapy, ARCALYST(rilonacept), marketed by Regeneron Pharmaceuticals, is based on a discovery by Hal Hoffman, M.D., associate professor of medicine at UCSD School of Medicine.
To help answer this question from a scientific perspective, a multidisciplinary group of researchers at the University of California, San Diego, along with colleagues at the Salk Institute for Biological Studies in La Jolla, have established a center to formally explore the origins of humanity and the many facets of what makes us human.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right